Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
Sugimoto K, Narimatsu H, Kawase T, Iida H, Watanabe M, Kohno A, Kuwatsuka Y, Uchida T, Hamaguchi M, Terakura S, Naoe T, Matsuo K, Murata M, Sawa M, Miyamura K, Morishita Y; Nagoya Blood and Marrow Transplantation Group (NBMTG). Sugimoto K, et al. Among authors: watanabe m. Bone Marrow Transplant. 2008 Apr;41(8):729-36. doi: 10.1038/sj.bmt.1705959. Epub 2008 Jan 7. Bone Marrow Transplant. 2008. PMID: 18176617
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y. Narimatsu H, et al. Among authors: watanabe m. Bone Marrow Transplant. 2007 Jan;39(1):31-9. doi: 10.1038/sj.bmt.1705539. Epub 2006 Nov 20. Bone Marrow Transplant. 2007. PMID: 17115066 Clinical Trial.
High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
Narimatsu H, Watanabe M, Kohno A, Sugimoto K, Kuwatsuka Y, Uchida T, Murata M, Miyamura K, Morishita Y; Nagoya Blood and Marrow Transplantation Group (NBMTG). Narimatsu H, et al. Among authors: watanabe m. Bone Marrow Transplant. 2008 Apr;41(8):753-6. doi: 10.1038/sj.bmt.1705978. Epub 2008 Jan 14. Bone Marrow Transplant. 2008. PMID: 18195683 Clinical Trial. No abstract available.
Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation.
Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, Fujisawa S, Kimura F, Emi N, Miura I, Fukuda T. Yanada M, et al. Among authors: watanabe m. Bone Marrow Transplant. 2013 Mar;48(3):390-5. doi: 10.1038/bmt.2012.159. Epub 2012 Sep 3. Bone Marrow Transplant. 2013. PMID: 22941379
Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.
Mori T, Watanabe M, Kurotori-Sotome T, Ito C, Yamada K, Yashima T, Kobayashi N, Kondo S, Aisa Y, Kato J, Ogawa Y, Tsubota K, Shigematsu N, Kubo A, Ikeda Y, Okamoto S. Mori T, et al. Among authors: watanabe m. Bone Marrow Transplant. 2008 Aug;42(3):197-9. doi: 10.1038/bmt.2008.152. Epub 2008 May 26. Bone Marrow Transplant. 2008. PMID: 18500372
Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, Watanabe M, Shimono Y, Deguchi T, Umemoto M, Higashikawa M, Kawasaki H, Komada Y, Sakurai M. Azuma E, et al. Among authors: watanabe m. Bone Marrow Transplant. 1997 Jun;19(11):1085-7. doi: 10.1038/sj.bmt.1700795. Bone Marrow Transplant. 1997. PMID: 9193750
14,208 results
You have reached the last available page of results. Please see the User Guide for more information.